Literature DB >> 3033070

Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1.

F S Di Giovine, S E Malawista, G Nuki, G W Duff.   

Abstract

We reported before that monosodium urate (MSU) crystals were potent stimulators of endogenous pyrogen (EP) production from human and rabbit mononuclear phagocytes, and proposed that this property of MSU crystals may be important in the pathogenesis of gout. EP activity is now attributed to interleukin 1 (IL 1) peptides but IL 1 is not the only pyrogenic monocyte-derived cytokine, since both interferon-alpha (alpha-IFN) and tumor necrosis factor (TNF) are also pyrogenic in rabbits. Using a T cell comitogenic assay based on a murine helper T cell clone that does not respond to IFN or TNF, we now report the release of IL 1 activity from human blood monocytes and synovial fluid mononuclear cells (MNC), following stimulation with MSU crystals. MSU-induced supernatants with IL 1 activity were neutralized with rabbit antiserum to human IL 1 and also stimulated the growth ([3H]thymidine incorporation) of long-term fibroblast-like cell lines derived from human synovial rheumatoid exudate. Two other crystals associated with articular inflammation were tested: hydroxyapatite was a much less potent stimulus compared with MSU crystals, and calcium pyrophosphate dihydrate did not stimulate IL 1 release from human monocytes or synovial fluid MNC. As a model for the inflammatory consequences of acute and chronic overproduction of IL 1, gout is the only sterile inflammatory disease where the local and systemic pathology is compatible with such overproduction; raised IL 1 levels have been found at the site of inflammation, and a necessary etiologic agent, crystalline urate, has been shown unequivocally to be a direct activator of mononuclear IL 1 release.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033070

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Expression and function of CXCL16 in a novel model of gout.

Authors:  Jeffrey H Ruth; Monica D Arendt; M Asif Amin; Salahuddin Ahmed; Hubert Marotte; Bradley J Rabquer; Charles Lesch; Solhee Lee; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2010-08

2.  Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice.

Authors:  Hal M Hoffman; Peter Scott; James L Mueller; Amir Misaghi; Sean Stevens; George D Yancopoulos; Andrew Murphy; David M Valenzuela; Ru Liu-Bryan
Journal:  Arthritis Rheum       Date:  2010-07

3.  Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra.

Authors:  D McGonagle; A L Tan; S Shankaranarayana; J Madden; P Emery; M F McDermott
Journal:  Ann Rheum Dis       Date:  2007-12       Impact factor: 19.103

4.  Sirt1 inhibits gouty arthritis via activating PPARγ.

Authors:  Juan Wang; Guangliang Chen; Liangjing Lu; Hejian Zou
Journal:  Clin Rheumatol       Date:  2019-07-31       Impact factor: 2.980

Review 5.  Anti-interleukin-1 therapy in the management of gout.

Authors:  Naomi Schlesinger
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

Review 6.  Sensing damage by the NLRP3 inflammasome.

Authors:  Jaklien C Leemans; Suzanne L Cassel; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

7.  Tumour necrosis factor in synovial exudates.

Authors:  F S Di Giovine; G Nuki; G W Duff
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

8.  Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells.

Authors:  S H P Oliveira; C Canetti; R A Ribeiro; F Q Cunha
Journal:  Inflammation       Date:  2008-02       Impact factor: 4.092

9.  Interaction of the cell-binding domain of fibronectin with VLA-5 integrin induces monokine production in cultured human monocytes.

Authors:  T Takizawa; S Nishinarita; N Kitamura; J Hayakawa; H Kang; Y Tomita; K Mitamura; K Yamagami; T Horie
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 10.  Mechanisms of inflammation in gout.

Authors:  Nathalie Busso; Alexander So
Journal:  Arthritis Res Ther       Date:  2010-04-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.